NO20081075L - Macrocykliske inhibitorer av hepatitt C virus - Google Patents

Macrocykliske inhibitorer av hepatitt C virus

Info

Publication number: NO20081075L
Authority: NO; Norway
Prior art keywords: alkylene; alkyl; carbocyclyl; hydrogen; heterocyclyl
Prior art date: 2005-07-29

Application number

NO20081075A

Other languages

English (en)

Norwegian (no)

Inventor

Herman Augustinus De Kock

Hans Wallberg

Pierre Jean-Marie Raboisson

Kenneth Alan Simmen

Lili Hu

Karl Magnus Nilsson

Bengt Bertil Samuelsson

Asa Annicka Kristina Rosenquist

Anna Karin Gertrud Linnea Belfrage

Mats Stefan Lindstrom

Pia Cecilia Kahnberg

Karin Charlotta Lindquist

Horst Juergen Wahling

Sven Christer Sahlberg

Bjorn Olof Classon

Original Assignee

Tibotec Pharm Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-07-29

Filing date

2008-02-29

Publication date

2008-04-25

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37708968&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20081075(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2008-02-29 Application filed by Tibotec Pharm Ltd filed Critical Tibotec Pharm Ltd

2008-04-25 Publication of NO20081075L publication Critical patent/NO20081075L/no

Links

241000711549 Hepacivirus C Species 0.000 title 1
239000003112 inhibitor Substances 0.000 title 1
125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 3
229910052739 hydrogen Inorganic materials 0.000 abstract 3
239000001257 hydrogen Substances 0.000 abstract 3
125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 3
125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 2
125000004916 (C1-C6) alkylcarbonyl group Chemical group 0.000 abstract 1
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 1
206010057199 Flaviviral infections Diseases 0.000 abstract 1
150000001204 N-oxides Chemical class 0.000 abstract 1
125000001246 bromo group Chemical group Br* 0.000 abstract 1
229910052799 carbon Inorganic materials 0.000 abstract 1
125000001309 chloro group Chemical group Cl* 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
125000000753 cycloalkyl group Chemical group 0.000 abstract 1
125000004663 dialkyl amino group Chemical group 0.000 abstract 1
125000004473 dialkylaminocarbonyl group Chemical group 0.000 abstract 1
125000001153 fluoro group Chemical group F* 0.000 abstract 1
-1 haloC 1 -C 6 alkyl Chemical group 0.000 abstract 1
125000005843 halogen group Chemical group 0.000 abstract 1
125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
238000011321 prophylaxis Methods 0.000 abstract 1
125000002294 quinazolinyl group Chemical group N1=C(N=CC2=CC=CC=C12)* 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
125000001424 substituent group Chemical group 0.000 abstract 1
238000011282 treatment Methods 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/10—Spiro-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D245/00—Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms
- C07D245/04—Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Virology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Molecular Biology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Plural Heterocyclic Compounds (AREA)

NO20081075A 2005-07-29 2008-02-29 Macrocykliske inhibitorer av hepatitt C virus NO20081075L (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
EP05107057		2005-07-29
EP06113097		2006-04-25
PCT/EP2006/064822 WO2007014927A2 (fr)	2005-07-29	2006-07-28	Inhibiteurs macrocycliques du virus de l'hepatite c

Publications (1)

Publication Number	Publication Date
NO20081075L true NO20081075L (no)	2008-04-25

Family

ID=37708968

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20081075A NO20081075L (no)	2005-07-29	2008-02-29	Macrocykliske inhibitorer av hepatitt C virus

Country Status (31)

Country	Link
US (1)	US7659245B2 (fr)
EP (1)	EP1912981B1 (fr)
JP (1)	JP5230418B2 (fr)
KR (1)	KR101083631B1 (fr)
AP (1)	AP2585A (fr)
AR (1)	AR057702A1 (fr)
AT (1)	ATE455775T1 (fr)
AU (1)	AU2006274866B2 (fr)
BR (1)	BRPI0614153A2 (fr)
CA (1)	CA2617103C (fr)
CY (1)	CY1110008T1 (fr)
DE (1)	DE602006011905D1 (fr)
DK (1)	DK1912981T3 (fr)
EA (1)	EA014188B1 (fr)
ES (1)	ES2339702T3 (fr)
GT (1)	GT200600343A (fr)
HR (1)	HRP20100209T1 (fr)
IL (1)	IL188320A (fr)
ME (1)	ME01454B (fr)
MY (1)	MY151026A (fr)
NO (1)	NO20081075L (fr)
NZ (1)	NZ564540A (fr)
PE (1)	PE20070343A1 (fr)
PL (1)	PL1912981T3 (fr)
PT (1)	PT1912981E (fr)
RS (1)	RS51227B (fr)
SI (1)	SI1912981T1 (fr)
SV (1)	SV2008002641A (fr)
TW (1)	TWI387597B (fr)
UY (1)	UY29704A1 (fr)
WO (1)	WO2007014927A2 (fr)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MY140680A (en)	2002-05-20	2010-01-15	Bristol Myers Squibb Co	Hepatitis c virus inhibitors
BRPI0506948B1 (pt)	2004-01-30	2018-09-18	Medivir Ab	inibidores de serina protease ns-3 de hcv
PE20070211A1 (es)	2005-07-29	2007-05-12	Medivir Ab	Compuestos macrociclicos como inhibidores del virus de hepatitis c
RU2436787C2 (ru)	2005-07-29	2011-12-20	Тиботек Фармасьютикалз Лтд.	Макроциклические ингибиторы вируса гепатита с
JO2768B1 (en) *	2005-07-29	2014-03-15	تيبوتيك فارماسيوتيكالز ليمتد	Large cyclic inhibitors of hepatitis C virus
WO2007014925A1 (fr)	2005-07-29	2007-02-08	Tibotec Pharmaceuticals Ltd.	Inhibiteurs macrocycliques du virus de l'hépatite c
BRPI0617274A2 (pt)	2005-10-11	2011-07-19	Intermune Inc	compostos e métodos para a inibição de replicação viral de hepatite c
US7741281B2 (en)	2005-11-03	2010-06-22	Bristol-Myers Squibb Company	Hepatitis C virus inhibitors
RU2008152171A (ru)	2006-07-05	2010-08-10	Интермьюн, Инк. (Us)	Новые ингибиторы вирусной репликации гепатита с
US7935670B2 (en)	2006-07-11	2011-05-03	Bristol-Myers Squibb Company	Hepatitis C virus inhibitors
DK2041156T3 (en)	2006-07-13	2014-02-24	Achillion Pharmaceuticals Inc	4-AMINO-4-OXOBUTANOYL Peptides AS INHIBITORS OF VIRUS REPLICATION
US8343477B2 (en)	2006-11-01	2013-01-01	Bristol-Myers Squibb Company	Inhibitors of hepatitis C virus
US7772180B2 (en)	2006-11-09	2010-08-10	Bristol-Myers Squibb Company	Hepatitis C virus inhibitors
US7763584B2 (en)	2006-11-16	2010-07-27	Bristol-Myers Squibb Company	Hepatitis C virus inhibitors
US8003604B2 (en)	2006-11-16	2011-08-23	Bristol-Myers Squibb Company	Hepatitis C virus inhibitors
US7888464B2 (en)	2006-11-16	2011-02-15	Bristol-Myers Squibb Company	Hepatitis C virus inhibitors
ES2470568T3 (es) *	2006-11-17	2014-06-24	Janssen R&D Ireland	Inhibidores macroc�clicos del virus de la hepatitis C
BRPI0806853B1 (pt) *	2007-02-01	2018-03-20	Janssen Sciences Ireland Uc	Processos e intermediários para preparar um inibidor de protease macrocíclico de hcv
BRPI0807087A2 (pt) *	2007-02-08	2014-06-10	Tibotec Pharm Ltd	Inibidores de hcv macrocíclicos substituídos de pirimidina
ITMI20071616A1 (it)	2007-08-03	2009-02-04	Cosmo Spa	Processo enzimatico per l'ottenimento di 17-alfa monoesteri del cortexolone e/o suoi 9,11-deidroderivati.
WO2009042668A2 (fr) *	2007-09-24	2009-04-02	Achillion Pharmaceuticals, Inc.	Peptides contenant de l'urée en tant qu'inhibiteurs de la réplication virale
US8383583B2 (en)	2007-10-26	2013-02-26	Enanta Pharmaceuticals, Inc.	Macrocyclic, pyridazinone-containing hepatitis C serine protease inhibitors
US8426360B2 (en) *	2007-11-13	2013-04-23	Enanta Pharmaceuticals, Inc.	Carbocyclic oxime hepatitis C virus serine protease inhibitors
US8263549B2 (en)	2007-11-29	2012-09-11	Enanta Pharmaceuticals, Inc.	C5-substituted, proline-derived, macrocyclic hepatitis C serine protease inhibitors
US8202996B2 (en)	2007-12-21	2012-06-19	Bristol-Myers Squibb Company	Crystalline forms of N-(tert-butoxycarbonyl)-3-methyl-L-valyl-(4R)-4-((7-chloro-4-methoxy-1-isoquinolinyl)oxy)-N- ((1R,2S)-1-((cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)-L-prolinamide
EP2226315A4 (fr)	2007-12-28	2012-01-25	Carna Biosciences Inc	Dérivé de 2-aminoquinazoline
CA2719008A1 (fr)	2008-03-20	2009-09-24	Enanta Pharmaceuticals, Inc.	Composes macrocycliques fluores en tant qu'inhibiteurs du virus de l'hepatite c
US8163921B2 (en)	2008-04-16	2012-04-24	Bristol-Myers Squibb Company	Hepatitis C virus inhibitors
EP2300491B1 (fr)	2008-05-29	2016-01-06	Bristol-Myers Squibb Company	Inhibiteurs du virus de l hépatite c
US7964560B2 (en)	2008-05-29	2011-06-21	Bristol-Myers Squibb Company	Hepatitis C virus inhibitors
US8207341B2 (en)	2008-09-04	2012-06-26	Bristol-Myers Squibb Company	Process or synthesizing substituted isoquinolines
UY32099A (es) *	2008-09-11	2010-04-30	Enanta Pharm Inc	Inhibidores macrocíclicos de serina proteasas de hepatitis c
US8563505B2 (en)	2008-09-29	2013-10-22	Bristol-Myers Squibb Company	Hepatitis C virus inhibitors
US8044087B2 (en)	2008-09-29	2011-10-25	Bristol-Myers Squibb Company	Hepatitis C virus inhibitors
AU2009324643B2 (en)	2008-12-10	2014-08-28	Achillion Pharmaceuticals, Inc.	New 4-amino-4-oxobutanoyl peptides as inhibitors of viral replication
US8283310B2 (en)	2008-12-15	2012-10-09	Bristol-Myers Squibb Company	Hepatitis C virus inhibitors
LT2401272T (lt)	2009-02-27	2017-03-27	Janssen Pharmaceuticals, Inc.	Hcv makrociklinio slopiklio amorfinė druska
WO2010118078A1 (fr)	2009-04-08	2010-10-14	Idenix Pharmaceuticals, Inc.	Inhibiteurs macrocycliques de la sérine protéase
NZ596546A (en) *	2009-05-29	2012-12-21	Syngenta Participations Ag	Substituted quinazolines as fungicides
TW201117812A (en)	2009-08-05	2011-06-01	Idenix Pharmaceuticals Inc	Macrocyclic serine protease inhibitors
CA2822556A1 (fr)	2010-12-30	2012-07-05	Enanta Pharmaceuticals, Inc	Inhibiteurs macrocycliques de serine protease d'hepatite c
US8951964B2 (en)	2010-12-30	2015-02-10	Abbvie Inc.	Phenanthridine macrocyclic hepatitis C serine protease inhibitors
WO2012109398A1 (fr)	2011-02-10	2012-08-16	Idenix Pharmaceuticals, Inc.	Inhibiteurs macrocycliques de sérine protéase, compositions pharmaceutiques les contenant et leur utilisation pour le traitement des infections par le vhc
US8957203B2 (en)	2011-05-05	2015-02-17	Bristol-Myers Squibb Company	Hepatitis C virus inhibitors
US10201584B1 (en)	2011-05-17	2019-02-12	Abbvie Inc.	Compositions and methods for treating HCV
US8691757B2 (en)	2011-06-15	2014-04-08	Bristol-Myers Squibb Company	Hepatitis C virus inhibitors
CA2858659A1 (fr)	2011-12-28	2013-07-04	Janssen R&D Ireland	Derives heterobicycliques en tant qu'inhibiteurs de vhc
NZ707115A (en) *	2012-10-15	2018-03-23	Albemarle Corp	Processes for the synthesis of 2-amino-4,6-dimethoxybenzamide and other benzamide compounds
BR112015007879A2 (pt)	2012-10-19	2017-07-04	Bristol Myers Squibb Co	inibidores do vírus da hepatite c
EP2914613B1 (fr)	2012-11-02	2017-11-22	Bristol-Myers Squibb Company	Inhibiteurs du virus de l'hépatite c
US9334279B2 (en)	2012-11-02	2016-05-10	Bristol-Myers Squibb Company	Hepatitis C virus inhibitors
US9643999B2 (en)	2012-11-02	2017-05-09	Bristol-Myers Squibb Company	Hepatitis C virus inhibitors
US9409943B2 (en)	2012-11-05	2016-08-09	Bristol-Myers Squibb Company	Hepatitis C virus inhibitors
EP2964664B1 (fr)	2013-03-07	2017-01-11	Bristol-Myers Squibb Company	Inhibiteurs du virus de l'hépatite c
US9006423B2 (en)	2013-03-15	2015-04-14	Achillion Pharmaceuticals Inc.	Process for making a 4-amino-4-oxobutanoyl peptide cyclic analogue, an inhibitor of viral replication, and intermediates thereof
US9085607B2 (en)	2013-03-15	2015-07-21	Achillion Pharmaceuticals, Inc.	ACH-0142684 sodium salt polymorph, composition including the same, and method of manufacture thereof
WO2015103490A1 (fr)	2014-01-03	2015-07-09	Abbvie, Inc.	Formes galéniques antivirales solides
EP3108879A1 (fr)	2015-06-25	2016-12-28	Cassiopea S.p.A.	Formulation à concentration élevée

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6323180B1 (en)	1998-08-10	2001-11-27	Boehringer Ingelheim (Canada) Ltd	Hepatitis C inhibitor tri-peptides
UA74546C2 (en) *	1999-04-06	2006-01-16	Boehringer Ingelheim Ca Ltd	Macrocyclic peptides having activity relative to hepatitis c virus, a pharmaceutical composition and use of the pharmaceutical composition
US6867185B2 (en) *	2001-12-20	2005-03-15	Bristol-Myers Squibb Company	Inhibitors of hepatitis C virus
NZ575692A (en)	2002-04-11	2009-10-30	Vertex Pharma	Inhibitors of Serine Proteases, Particularly Hepatitis C Virus NS3-NS4 Protease
MY140680A (en)	2002-05-20	2010-01-15	Bristol Myers Squibb Co	Hepatitis c virus inhibitors
US20050075279A1 (en) *	2002-10-25	2005-04-07	Boehringer Ingelheim International Gmbh	Macrocyclic peptides active against the hepatitis C virus
US20040180815A1 (en) *	2003-03-07	2004-09-16	Suanne Nakajima	Pyridazinonyl macrocyclic hepatitis C serine protease inhibitors
WO2004072243A2 (fr) *	2003-02-07	2004-08-26	Enanta Pharmaceuticals, Inc.	Inhibiteurs macrocycliques de la serine protease de l'hepatite c
EP1629000B1 (fr) *	2003-04-16	2009-02-18	Bristol-Myers Squibb Company	Peptide d'isoquinoleine macrocyclique inhibiteurs du virus de l'hepatite c
US7125845B2 (en) *	2003-07-03	2006-10-24	Enanta Pharmaceuticals, Inc.	Aza-peptide macrocyclic hepatitis C serine protease inhibitors
UY28525A1 (es) *	2003-09-22	2005-04-29	Boehringer Ingelheim Int	Péptidos macrociclicos activos contra en virus de la hepatitis c
BRPI0506948B1 (pt) *	2004-01-30	2018-09-18	Medivir Ab	inibidores de serina protease ns-3 de hcv
PE20070211A1 (es) *	2005-07-29	2007-05-12	Medivir Ab	Compuestos macrociclicos como inhibidores del virus de hepatitis c
TWI393723B (zh) *	2005-07-29	2013-04-21	Tibotec Pharm Ltd	Ｃ型肝炎病毒之大環抑制劑（九）
US7700552B2 (en) *	2005-07-29	2010-04-20	Medivir Ab	Macrocyclic inhibitors of hepatitis C virus
TWI383980B (zh) *	2005-07-29	2013-02-01	Tibotec Pharm Ltd	Ｃ型肝炎病毒之大環抑制劑

2006
- 2006-07-26 PE PE2006000903A patent/PE20070343A1/es not_active Application Discontinuation
- 2006-07-28 HR HR20100209T patent/HRP20100209T1/hr unknown
- 2006-07-28 ES ES06764268T patent/ES2339702T3/es active Active
- 2006-07-28 PL PL06764268T patent/PL1912981T3/pl unknown
- 2006-07-28 UY UY29704A patent/UY29704A1/es unknown
- 2006-07-28 AU AU2006274866A patent/AU2006274866B2/en not_active Ceased
- 2006-07-28 AT AT06764268T patent/ATE455775T1/de active
- 2006-07-28 SI SI200630627T patent/SI1912981T1/sl unknown
- 2006-07-28 ME MEP-2012-119A patent/ME01454B/me unknown
- 2006-07-28 PT PT06764268T patent/PT1912981E/pt unknown
- 2006-07-28 KR KR1020087004894A patent/KR101083631B1/ko not_active Expired - Fee Related
- 2006-07-28 GT GT200600343A patent/GT200600343A/es unknown
- 2006-07-28 TW TW095127585A patent/TWI387597B/zh not_active IP Right Cessation
- 2006-07-28 CA CA2617103A patent/CA2617103C/fr not_active Expired - Fee Related
- 2006-07-28 DE DE602006011905T patent/DE602006011905D1/de active Active
- 2006-07-28 MY MYPI20063670 patent/MY151026A/en unknown
- 2006-07-28 BR BRPI0614153-6A patent/BRPI0614153A2/pt not_active Application Discontinuation
- 2006-07-28 NZ NZ564540A patent/NZ564540A/en not_active IP Right Cessation
- 2006-07-28 WO PCT/EP2006/064822 patent/WO2007014927A2/fr not_active Ceased
- 2006-07-28 AP AP2008004306A patent/AP2585A/xx active
- 2006-07-28 US US11/995,900 patent/US7659245B2/en not_active Expired - Fee Related
- 2006-07-28 AR ARP060103303A patent/AR057702A1/es not_active Application Discontinuation
- 2006-07-28 JP JP2008523383A patent/JP5230418B2/ja not_active Expired - Fee Related
- 2006-07-28 DK DK06764268.6T patent/DK1912981T3/da active
- 2006-07-28 RS RSP-2010/0183A patent/RS51227B/sr unknown
- 2006-07-28 EA EA200800482A patent/EA014188B1/ru not_active IP Right Cessation
- 2006-07-28 EP EP06764268A patent/EP1912981B1/fr active Active
- 2006-07-29 SV SV2006002641A patent/SV2008002641A/es unknown
2007
- 2007-12-20 IL IL188320A patent/IL188320A/en not_active IP Right Cessation
2008
- 2008-02-29 NO NO20081075A patent/NO20081075L/no not_active Application Discontinuation
2010
- 2010-04-20 CY CY20101100355T patent/CY1110008T1/el unknown

Also Published As

Publication number	Publication date
JP2009502890A (ja)	2009-01-29
DK1912981T3 (da)	2010-05-25
TW200745116A (en)	2007-12-16
SV2008002641A (es)	2008-07-23
HK1116488A1 (en)	2008-12-24
EA014188B1 (ru)	2010-10-29
WO2007014927A3 (fr)	2007-11-29
RS51227B (sr)	2010-12-31
ATE455775T1 (de)	2010-02-15
DE602006011905D1 (de)	2010-03-11
KR20080033475A (ko)	2008-04-16
WO2007014927A2 (fr)	2007-02-08
TWI387597B (zh)	2013-03-01
AU2006274866B2 (en)	2012-04-12
AR057702A1 (es)	2007-12-12
IL188320A (en)	2014-07-31
BRPI0614153A2 (pt)	2011-03-15
CA2617103A1 (fr)	2007-02-08
SI1912981T1 (sl)	2010-05-31
MY151026A (en)	2014-03-31
PL1912981T3 (pl)	2010-07-30
EP1912981A2 (fr)	2008-04-23
EP1912981B1 (fr)	2010-01-20
IL188320A0 (en)	2008-04-13
KR101083631B1 (ko)	2011-11-16
AP2585A (en)	2013-02-04
NZ564540A (en)	2010-03-26
PE20070343A1 (es)	2007-05-12
CY1110008T1 (el)	2015-01-14
US20090118312A1 (en)	2009-05-07
HRP20100209T1 (hr)	2010-05-31
JP5230418B2 (ja)	2013-07-10
EA200800482A1 (ru)	2008-06-30
GT200600343A (es)	2007-08-06
ES2339702T3 (es)	2010-05-24
ME01454B (me)	2014-04-20
UY29704A1 (es)	2007-05-31
AU2006274866A1 (en)	2007-02-08
CA2617103C (fr)	2015-01-06
US7659245B2 (en)	2010-02-09
PT1912981E (pt)	2010-04-16

Legal Events

Date	Code	Title	Description
2016-02-29	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
NO20081075L (no)	2008-04-25	Macrocykliske inhibitorer av hepatitt C virus
NO20080879L (no)	2008-04-17	HCV-NS3-proteaseinhibitorer
NO20090595L (no)	2009-04-07	Ny pyridazinforbindelse og anvendelse derav
TNSN07252A1 (en)	2008-12-31	Indole derivatives for treating viral infections
IN2012DN00999A (fr)	2015-04-10
MX2012007420A (es)	2012-07-23	Analogos para el tratamiento o prevencion de infecciones de flavivirus.
MX2012008443A (es)	2012-08-15	Nucleosidos antiviricos.
PE20090478A1 (es)	2009-05-24	Compuestos de indol macrociclicos como inhibidores de la proteasa del virus de la hepatitis c
MY140729A (en)	2010-01-15	Amide derivatives
WO2007103550A3 (fr)	2007-11-08	Derives d'aminothiazole substitues presentant une activite anti-hcv
WO2010062821A8 (fr)	2010-09-30	Composés antiviraux, compositions, et procédés d’utilisation
WO2010063996A3 (fr)	2010-12-29	Composés antibactériens
TW200732336A (en)	2007-09-01	Alyphactic heterocyclic compounds
NO20063407L (no)	2006-09-26	Benzenforbindelser disubstituert med cykliske grupper i 1- og 2-posisjoner
DE60112933D1 (de)	2005-09-29	N-phenyl-4-(4-pyridyl)-2-pyrimidinamine-derivate
NO20076680L (no)	2008-04-30	Utvalgte CGRP-antagonister, metoder for fremstilling av disse og deres anvendelse som medikamenter
MY140868A (en)	2010-01-29	Amide derivatives
TW200640879A (en)	2006-12-01	Amide derivatives
NO20053570L (no)	2006-01-23	Termostabilt, vannopploselig polymer som er tverrbindbar ved hoye temperaturer
NO20084804L (no)	2009-02-16	Disazosyre-fargestoffer
TW200728291A (en)	2007-08-01	Amide derivatives
NO20076389L (no)	2008-02-20	Sammenstninger og metoder for behandling av HIV-infeksjon med cupredoxin og cytokrom C
CO5630031A2 (es)	2006-04-28	Derivados de benzotiazol como ligandos del receptor adenosina
TW200609228A (en)	2006-03-16	Substituted n-acyl-2-aminothiazoles
NO20081083L (no)	2008-02-29	Antitumorforbindelser